Table 2

Comparison of characteristics and clinical findings between men and women

VariableWomenMenp Value
n=62n=21
Age, median (range)56 (25–84)44 (23–77)0.30
Caucasian, n (%)46 (74.2)16 (76.2)1
Ophthalmological findings, n (%)
 Intraocular manifestations0.67
  Anterior11 (17.7)5 (23.8)
  Anterior intermediate7 (11.3)3 (14.3)
  Intermediate5 (8.1)0 (0)
  Posterior6 (9.7)3 (14.3)
  Panuveitis33 (53.2)10 (47.6)
 Chronic form43 (76.8)11 (55)0.12
 Bilateral involvement46 (74.2)16 (76.2)1
 Granulomatous uveitis36 (59)11 (52.4)0.78
 Elevated IOP3 (4.8)1 (4.8)1
 CME29 (48.3)3 (14.3)0.01
 PMC22 (36.7)5 (23.8)0.42
Serum markers, n (%)
 High ACE38 (63.3)12 (57.1)0.81
 Normal ACE22 (36.7)9 (42.9)
 High lysozyme level38 (82.6)14 (87.5)1
 Normal lysozyme level8 (17.4)2 (12.5)
Chest imaging, n (%)
 Abnormal chest X-rays34 (58.6)15 (75)0.3
 Abnormal chest CTs54 (90)19 (95)0.67
  • CME, chronic macular oedema; elevated IOP: chronically elevated intraocular pressure >21 mm Hg resulting from damage of angle; PMC, peripheral multifocal choroiditis.